Sponsor Pipeline

Protagonist Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Phase 3
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07153146
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy…		 Trial completed
2026-08-06 NCT07153146
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy…		 date change Primary completion pushed: 2026-06-15 -> 2026-07-29
2026-08-06 NCT07153146
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy…		 date change Completion pushed: 2026-06-15 -> 2026-07-29
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06033586 Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With… Polycythemia Vera Active, Not Recruiting
NCT05210790 A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera Polycythemia Vera Active, Not Recruiting
Get alerts when Protagonist Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free